ClinicalTrials.govpublic full text
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
ovarian cancer, fallopian tube, primary peritoneal cancer, first line treatment, advanced epithelial ovarian cancer, mirvetuximab soravtansine, imgn853, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847095
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.